CRISPR Therapeutics AG (CRSP) IPO Opens Up 7%

October 19, 2016 10:37 AM EDT
Get Alerts CRSP Hot Sheet
Trade CRSP Now!
Join SI Premium – FREE

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Today's IPO for CRISPR Therapeutics AG (Nasdaq: CRSP) opened for trading at $15 after pricing its initial public offering of 4,000,000 common shares at a public offering price of $14.00 per share.

Citigroup, Piper Jaffray and Barclays are acting as joint book-running managers for the offering. Guggenheim Securities is acting as co-manager.

CRISPR Therapeutics is a leading gene-editing company focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Piper Jaffray, Citi, Barclays, IPO, Guggenheim

Add Your Comment